Michael Thomas Henderson - Net Worth and Insider Trading
Michael Thomas Henderson Net Worth
The estimated net worth of Michael Thomas Henderson is at least $84 Million dollars as of 2024-11-05. Michael Thomas Henderson is the CEO of Apogee Therapeutics Inc and owns about 1,354,487 shares of Apogee Therapeutics Inc (APGE) stock worth over $77 Million. Michael Thomas Henderson is also the Chief Business Officer of BridgeBio Pharma Inc and owns about 274,211 shares of BridgeBio Pharma Inc (BBIO) stock worth over $7 Million. Details can be seen in Michael Thomas Henderson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Thomas Henderson has not made any transactions after 2024-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Thomas Henderson
Michael Thomas Henderson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Thomas Henderson owns 4 companies in total, including BridgeBio Pharma Inc (BBIO) , Adagio Medical Holdings Inc (ADGM) , and Spyre Therapeutics Inc (SYRE) among others .
Click here to see the complete history of Michael Thomas Henderson’s form 4 insider trades.
Insider Ownership Summary of Michael Thomas Henderson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BBIO | BridgeBio Pharma Inc | 2020-12-01 | See Remarks |
| ADGM | Adagio Medical Holdings Inc | 2021-02-25 | director |
| SYRE | Spyre Therapeutics Inc | 2023-06-22 | director |
 | | 2024-10-02 | director & Chief Executive Officer |
Michael Thomas Henderson Latest Holdings Summary
Michael Thomas Henderson currently owns a total of 2 stocks. Among these stocks, Michael Thomas Henderson owns 1,354,487 shares of Apogee Therapeutics Inc (APGE) as of October 2, 2024, with a value of $77 Million and a weighting of 91.84%. Michael Thomas Henderson also owns 274,211 shares of BridgeBio Pharma Inc (BBIO) as of December 1, 2020, with a value of $7 Million and a weighting of 8.16%.
Latest Holdings of Michael Thomas Henderson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APGE | Apogee Therapeutics Inc | 2024-10-02 | 1,354,487 | 56.67 | 76,752,006 |
| BBIO | BridgeBio Pharma Inc | 2020-12-01 | 274,211 | 24.87 | 6,819,628 |
Holding Weightings of Michael Thomas Henderson
Michael Thomas Henderson Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Thomas Henderson has made a total of 4 transactions in Apogee Therapeutics Inc (APGE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Apogee Therapeutics Inc is the sale of 40,000 shares on October 2, 2024, which brought Michael Thomas Henderson around $2 Million.
According to the SEC Form 4 filings, Michael Thomas Henderson has made a total of 17 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in BridgeBio Pharma Inc is the sale of 10,000 shares on December 1, 2020, which brought Michael Thomas Henderson around $515,200.
Insider Trading History of Michael Thomas Henderson
- 1
Michael Thomas Henderson Trading Performance
GuruFocus tracks the stock performance after each of Michael Thomas Henderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Thomas Henderson is -23.64%. GuruFocus also compares Michael Thomas Henderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Thomas Henderson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Thomas Henderson's insider trading performs compared to the benchmark.
Performance of Michael Thomas Henderson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.48 | | | | | |
| Relative Return to S&P 500(%) | 8.84 | | | | | |
Michael Thomas Henderson Ownership Network
Ownership Network List of Michael Thomas Henderson
Ownership Network Relation of Michael Thomas Henderson
Michael Thomas Henderson Owned Company Details
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Michael Thomas Henderson is the See Remarks of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include 10 percent owner Kkr Genetic Disorder L.p. , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Michael Thomas Henderson made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 12,000 shares made by Randal W Scott , a net sale of 182,045 shares made by Neil Kumar , and a net sale of 73,947 shares made by Brian C Stephenson .
In summary, during the past 3 months, insiders sold 5,831,544 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 5,831,544 shares. During the past 18 months, 7,676,737 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,676,737 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
Michael Thomas Henderson Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Thomas Henderson. You might contact Michael Thomas Henderson via mailing address: 421 Kipling Street, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
